ES8600752A1 - Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.

Info

Publication number
ES8600752A1
ES8600752A1 ES533389A ES533389A ES8600752A1 ES 8600752 A1 ES8600752 A1 ES 8600752A1 ES 533389 A ES533389 A ES 533389A ES 533389 A ES533389 A ES 533389A ES 8600752 A1 ES8600752 A1 ES 8600752A1
Authority
ES
Spain
Prior art keywords
intraocular pressure
derivatives
thiophenesulfonamide
topical treatment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES533389A
Other languages
English (en)
Other versions
ES533389A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/505,604 external-priority patent/US4486444A/en
Priority claimed from US06/505,673 external-priority patent/US4542152A/en
Priority claimed from US06/505,618 external-priority patent/US4477466A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8600752A1 publication Critical patent/ES8600752A1/es
Publication of ES533389A0 publication Critical patent/ES533389A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE NUEVOS DERIVADOS DE TIOFENSULFONAMIDA.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III) PARA OBTENER DERIVADOS DE TIOFENSULFONAMIDA O SALES OFTALMOLOGICAMENTE ACEPTABLES DE LOS MISMOS, DONDE X ES; N ES 0 O 1; Y R ES ALQUILO C 1 A 8 DE CADENA LINEAL O RAMIFICADA, HALOALQUILO C 1 A 18 DONDE HALO ES CLORO, BROMO O FLUOR, ALCOXI C 1 A 13 CARBONIL ALQUILO C 1 A 15, CICLOALQUILO C 3 A 6 Y OTROS. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE TAL COMO DIMETILFORMAMIDA, PIRIDINA, ACETONA, ACETATO DE ETILO Y OTROS, CON O SIN UN CATALIZADOR Y A TEMPERATURA ENTRE 0JC Y LA DEL PUNTO DE EBULLICION DEL DISOLVENTE.SON UTILES EN EL TRATAMIENTO DE LA PRESION INTRAOCULAR ELEVADA Y PARA EL TRATAMIENTO DE LA ENFERMEDAD CONOCIDA COMO GLAUCOMA.
ES533389A 1983-06-20 1984-06-13 Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida. Granted ES533389A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/505,604 US4486444A (en) 1983-06-20 1983-06-20 (Hydroxybenzoyl)thiophenesulfonamide and acyl derivatives thereof for the topical treatment of elevated intraocular pressure
US06/505,673 US4542152A (en) 1983-05-23 1983-06-20 5-[Phenylsulfonyl(or sulfinyl)]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US06/505,618 US4477466A (en) 1983-05-23 1983-06-20 Acyloxy derivatives of [phenylsulfonyl(or sulfinyl)]thiophenesulfonamide for the topical treatment of elevated intraocular pressure

Publications (2)

Publication Number Publication Date
ES8600752A1 true ES8600752A1 (es) 1985-10-16
ES533389A0 ES533389A0 (es) 1985-10-16

Family

ID=27414296

Family Applications (1)

Application Number Title Priority Date Filing Date
ES533389A Granted ES533389A0 (es) 1983-06-20 1984-06-13 Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.

Country Status (4)

Country Link
EP (1) EP0130109B1 (es)
CA (1) CA1219867A (es)
DE (1) DE3479728D1 (es)
ES (1) ES533389A0 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182691B1 (en) * 1984-11-02 1990-07-04 Merck & Co. Inc. Substituted thiophene-2-sulfonamides and their preparation
US4665090A (en) * 1985-10-09 1987-05-12 Merck & Co., Inc. Substituted thiophene-2-sulfonamide antiglaucoma agents
DE3667056D1 (en) * 1985-12-24 1989-12-28 Merck & Co Inc Substituted thiophene-2-sulfonamide antiglaucoma agents
US4677113A (en) * 1986-04-22 1987-06-30 Riker Laboratories, Inc. Di-t-butylphenols substituted by a thenoyl group
US4847289A (en) * 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
DK641189A (da) * 1988-12-19 1990-06-20 Merck & Co Inc Praeparat til behandling af glaucom og fremgangsmaade til fremstilling af et saadant praeparat
EP0375299A1 (en) * 1988-12-19 1990-06-27 Merck & Co. Inc. Combinations of angiotensin converting enzyme, and carbonic anhydrase, inhibitors for treating glaucoma
US5300499A (en) * 1992-09-02 1994-04-05 Allergan, Inc. 5-substituted 3-thiophene sulfonamides as antiglaucoma agents
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459571A (en) * 1974-09-12 1976-12-22 Pfizer Ltd Thiophene-2-sulphonamide derivatives and their use as therapeutic agents sheet orienting apparatus
GB1468111A (en) * 1976-01-08 1977-03-23 Pfizer Ltd Thiophene-sulphonamides
ZA813332B (en) * 1980-06-21 1982-05-26 Pfizer Larvicides and isecticides
AR241136A1 (es) * 1981-07-13 1991-11-29 Merck E Co Inc Procedimiento para preparar esteres de 6-hidroxi-2-benzotiazolsulfonamida para tratamiento topicode presion intraocular elevada"
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure

Also Published As

Publication number Publication date
EP0130109B1 (en) 1989-09-13
DE3479728D1 (en) 1989-10-19
CA1219867A (en) 1987-03-31
EP0130109A3 (en) 1986-11-26
EP0130109A2 (en) 1985-01-02
ES533389A0 (es) 1985-10-16

Similar Documents

Publication Publication Date Title
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
MY106259A (en) 2-aminopyrimidinone derivatives.
GR3025940T3 (en) Heterocyclic derivatives of acylaminothiazole, their preparation and pharmaceutical compositions containing them.
CA2080223A1 (en) Thiophene sulfonamides useful as carbonic anhydrase inhibitors
ES8405387A1 (es) Un procedimiento para la preparacion de derivados de benzotia-zolsulfonamida.
AU2454788A (en) N-substituted derivatives of 1-desoxynojirimycin 1- desoxymannojirimycin, processes for their preparation and their use in medicaments
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
EP0142426A3 (en) Ophthalmic formulation containing norfloxacin and related antibiotics
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
GR3006815T3 (es)
ES8600752A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
UA60352C2 (uk) Синтетичні полісахариди та фармацевтична композиція, що їх містить
ES475633A1 (es) Procedimiento para la obtencion de derivados de 1-n-4,6-di-0-(aminoglicosil)-1,3-diamino-ciclitol.
ES8600272A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-sulfamoilbenzo (b) tiofeno.
EP0162208A3 (en) Novel n-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ES8400417A1 (es) "procedimiento para la preparacion de esteres carboxilicos de 6-hidroxi-2-benzotiazolsulfonamida".
AU6697786A (en) New derivatives of 1-sulphonyl 2-oxo-5-alkoxy pyrrolidine, their preparation process, their use as medicaments and the compositions containing them
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
IL86173A0 (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303